Mintao Zhong

Dr. Mintao Zhong


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2018 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
SSSHIYU SONG
SHIYU SONG
MVMiza S. Vuai
Miza S. Vuai
MZMintao Zhong
Mintao Zhong
In recent decades, bacteria’s therapeutic role has aroused attention in medicinal and pharmaceutical research. While bacteria are considered among the primary agents for causing cancer, recent research has shown intriguing results suggesting that bacteria can be effective agents for cancer treatment – they are the perfect vessels for targeted cancer therapy. Several bacterial strains/species have been discovered to possess inherent oncolytic potentials to invade and colonize solid tumors in vivo. The therapeutic strategy of using bacteria for treating cancer is considered to be effective; however, the severe side effects encountered during the treatment resulted in the abandonment of the therapy. State-of-the-art genetic engineering has been recently applied to bacteria therapy and resulted in a greater efficacy with minimum side effects. In addition, the anti-cancer potential of tumor-targeting bacteria through oral administration circumvents the use of the intravenous route and the associated adverse effects. This review aims to provide a comprehensive summary of the latest literature on the role of bacteria in cancer treatment.

24 July 2015 in FEMS Microbiology Letters
Verified
Journal Article
Closed access
PDF file
WWWendong Wang
Wendong Wang
WCWarren Chanda
Warren Chanda
MZMintao Zhong
Mintao Zhong
Microorganisms have the ability of inhabiting nearly every environment through their sophisticated mechanisms of survival such as biofilm formation and release of outer membrane vesicles (OMVs). The biofilm matrix offers microorganism protection and contributes significantly to several clinical challenges, including symptomatic inflammation, antibiotic resistance, recurrence and the spread of infectious emboli. Moreover, bacteria also have another protective mechanism of vesicle production which is used as a means of disseminating toxins to harm their host. A clear understanding of gene expression switch of bacterium from planktonic to biofilm mode offers clinical potentials in treating bacterial infections. In this respect, the treatment of bacterial infections may be achieved through (1) application of RNA interference technology to silence the expression of proteins involved in the process of biofilm formation, (2) utilization of vesicles in delivering antibiotics and (3) use of natural occurred compounds. In this review, we discuss the relationship between biofilm formation and OMV production with respect to tackling biofilm-related clinical challenges. Some prospective considerations in biofilm-associated infections treatment are also discussed.

20 April 2018 in Journal of Zhejiang University-SCIENCE B
Verified
Journal Article
Closed access
PDF file
WCWarren Chanda
Warren Chanda
TJThomson P. Joseph
Thomson P. Joseph
XGXue-Fang Guo
Xue-Fang Guo
WWWen-Dong Wang
Wen-Dong Wang
MLMin Liu
Min Liu
MZMintao Zhong
Mintao Zhong
Microorganisms provide both beneficial and harmful effects to human beings. Beneficial effects come from the symbiotic relationship that exists between humans and microbiota, but then several human...

28 August 2023 in Journal of the Science of Food and Agriculture
Verified
Journal Article
Closed access
XGXiaorong Guo
Xiaorong Guo
LLLei Liu
Lei Liu
WZWenqi Zhao
Wenqi Zhao
XLXingyun Li
Xingyun Li
XWXiaoli Wang
Xiaoli Wang
MZMintao Zhong
Mintao Zhong

1 September 2017 in Medical Hypotheses
Verified
Journal Article
Closed access
WCWarren Chanda
Warren Chanda
TJThomson P. Joseph
Thomson P. Joseph
WWWendong Wang
Wendong Wang
APArshad A. Padhiar
Arshad A. Padhiar
MZMintao Zhong
Mintao Zhong

5 September 2017 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
WCWarren Chanda
Warren Chanda
TJThomson Patrick Joseph
Thomson Patrick Joseph
APArshad Ahmed Padhiar
Arshad Ahmed Padhiar
XGXuefang Guo
Xuefang Guo
LMLiu Min
Liu Min
MZMintao Zhong
Mintao Zhong
Pseudomonas aeruginosa is a ubiquitous Gram negative opportunistic pathogen capable of causing severe nosocomial infections in humans, and tobramycin is currently used to treat P. aeruginosa associated lung infections. Quorum sensing regulates biofilm formation which allows the bacterium to result in fatal infections forcing clinicians to extensively use antibiotics to manage its infections leading to emerging multiple drug resistant strains. As a result, tobramycin is also becoming resistant. Despite extensive studies on drug discovery to alleviate microbial drug resistance, the continued microbial evolution has forced researchers to focus on screening various phytochemicals and dietary compounds for antimicrobial potential. Linolenic acid (LNA) is an essential fatty acid that possesses antimicrobial actions on various microorganisms. It was hypothesized that LNA may affect the formation of biofilm on P. aeruginosa and improve the potency of tobramycin. The present study demonstrated that LNA interfered with cell‑to‑cell communication and reduced virulence factor production. It further enhanced the potency of tobramycin and synergistically inhibited biofilm formation through P. aeruginosa quorum sensing systems. Therefore, LNA may be considered as a potential agent for adjunctive therapy and its utilization may decrease tobramycin concentration in combined treatment thereby reducing aminoglycoside adverse effects.